Page 6 - Interventional Solutions News Today : Breaking News, Live Updates & Top Stories | Vimarsana

/PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced results for third-quarter 2021. "Our third-quarter results demonstrate solid performance across...

2  3  4  Other modeling considerations will be provided on the webcast. WEBCAST INFORMATION: Johnson & Johnson will conduct a conference call with investors to discuss this earnings release today at 8:30 a.m., Eastern Time. A simultaneous webcast of the call for investors and other interested parties may be accessed by visiting the Johnson & Johnson website. A replay and podcast will be available approximately two hours after the live webcast in the Investors section of the company's website at events-and-presentations.  ABOUT JOHNSON & JOHNSON: At Johnson & Johnson, we believe good heal...

Philips Spotlights New Integrated Informatics and System Solutions to Drive Workflow Optimization and Advance Precision Diagnosis at ECR 2021 Font : A-A+   Expanded Philips Radiology Workflow Suite features new, AI-enabled solutions to streamline workflows across the entire imaging enterprise Solutions integrate and automate workflow to help improve efficiency and clinical confidence to enable earlier and more definitive diagnosis Philips’ portfolio of award-winning diagnostic systems and interventional solutions will be featured in a unique virtual ECR experience Amsterdam, the Netherlan...

Royal Philips: Philips spotlights new integrated informatics and system solutions to drive workflow optimization and advance precision diagnosis at ECR 2021 Expanded Philips Radiology Workflow Suite features new, AI-enabled solutions to streamline workflows across the entire imaging enterprise Solutions integrate and automate workflow to help improve efficiency and clinical confidence to enable earlier and more definitive diagnosis Philips' portfolio of award-winning diagnostic systems and interventional solutions will be featured in a unique virtual ECR experience Amsterdam, the Netherlands...

Share this article Share this article NEW BRUNSWICK, N.J., Jan. 26, 2021 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2020. "Our notable full year performance reflects the continued confidence from patients, physicians, customers and consumers in our life-enhancing products and medicines, particularly throughout the COVID-19 pandemic," said Alex Gorsky, Chairman and Chief Executive Officer. "I'm incredibly proud of our Johnson & Johnson teams around the world for going above and beyond to meet stakeholder needs. These efforts, and our...